Debendox and congenital malformations in Northern Ireland

Harron, D.W.G.; Griffiths, K.; Shanks, R.G.
November 1980
British Medical Journal;11/22/1980, Vol. 281 Issue 6252, p1379
Academic Journal
Investigates the association of Debendox with congenital abnormalities in Northern Ireland. Environmental factors contributing to a decrease in congenital abnormalities; Influence of drugs on the incidence of fetal abnormalities; Reduction in the incidence of congenital malformations.


Related Articles

  • Conception and congenital abnormalities after chemotherapy of acute myelogenous leukemia in two men.  // British Medical Journal;6/19/1976, Vol. 1 Issue 6024, p1508 

    Presents case reports on the congenital abnormalities after chemotherapy of acute myelogenous leukaemia. Efficacy of chemotherapy for malignant disease treatment; Complications on testicular and ovarian functioning; Examination of congenital abnormalities among offspring.

  • Use of metronidazole and incidence of birth defects.  // American Family Physician;1/1/1994, Vol. 49 Issue 1, p205 

    Focuses on the use of metronidazole and incidence of birth defects as studied by Piper and colleagues and reported in the September 1993 issue of `Obstetrics and Gynecology.' Concerns about teratogenicity; Lack of evidence to indicate birth defects as attributable to metronidazole.

  • Effects of acyclovir on pregnancy outcome.  // American Family Physician;1/1/1994, Vol. 49 Issue 1, p256 

    Summarizes a report on the effects of acyclovir on pregnancy outcome which appeared in the October 22, 1993 issue of the `Morbidity and Mortality Weekly Report.' Lack of indication of effects on newborn infants; Diseases treated by acyclovir.

  • Phenytoin.  // Reactions Weekly;10/19/2013, Issue 1474, p36 

    The article presents a case study of an 8-year-old girl who developed anonychia after phenytoin exposure in utero.

  • ACNE CONTROL VS. BIRTH DEFECTS: Accutane spurs lawsuits, called thalidomide of the '80s. Blodgett, Nancy // ABA Journal;Jul88, Vol. 74 Issue 7, p17 

    Investigates claims that Accutane, a drug for acute acne, causes severe birth defects in the United States. Accusation that drug maker Roche Laboratories failed to provide warning of the drug's dangers; Recommendation to restrict drug distribution to young women; Allegation that the drug was...

  • BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs. Matok, Ilan; Levy, Amalia; Gorodischer, Rafael; Lunenfeld, Eitan; Limony, Yehuda; Koren, Gideon // Current Drug Safety;Feb2011, Vol. 6 Issue 1, p40 

    We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for...

  • New paroxetine pregnancy alert. Cressey, Daniel // Pulse;10/8/2005, Vol. 65 Issue 39, p7 

    Reports that GlaxoSmithKline PLC has issued a worldwide warning on the use of paroxetine after new research linked the drug to birth defects. Increase the risk of congenital malformation when used during the first trimester; Encouragement of physicians to exercise caution in using the drug in...

  • How Safe is Acetaminophen and Pregnancy? Hobbins, John C. // OB/GYN Clinical Alert;Jun2008, Vol. 25 Issue 2, p14 

    A study evaluates whether acetaminophen, one of the most frequently used drugs among pregnant women, is associated with an increased prevalence of congenital abnormalities.

  • Prozac linked with minor birth defects. Mayor, Susan // BMJ: British Medical Journal (International Edition);10/12/96, Vol. 313 Issue 7062, p902 

    Reports on the possibility that Prozac taken during the third trimester of the pregnancy may result to minor abnormalities. Research conducted at the University of California; Risks of premature delivery; Association of antidepressants to neonatal withdrawal symptoms.


Read the Article


Sign out of this library

Other Topics